Cas 916343-07-2,4-(3-methanesulfonyloxy-benzoylamino)-piperidine-1-carboxylic acid tert-butyl ester

916343-07-2

Post Buying Request

Basic information

Product Name: 4-(3-methanesulfonyloxy-benzoylamino)-piperidine-1-carboxylic acid tert-butyl ester
Synonyms: 4-(3-methanesulfonyloxy-benzoylamino)-piperidine-1-carboxylic acid tert-butyl ester
CAS NO:916343-07-2
Molecular Formula:
Molecular Weight: 398.48
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(3-methanesulfonyloxy-benzoylamino)-piperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-(3-methanesulfonyloxy-benzoylamino)-piperidine-1-carboxylic acid tert-butyl ester(916343-07-2)
EPA Substance Registry System: 4-(3-methanesulfonyloxy-benzoylamino)-piperidine-1-carboxylic acid tert-butyl ester(916343-07-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 916343-07-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

916343-07-2 Suppliers

Recommended suppliers

916343-07-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 916343-07-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,3,4 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 916343-07:
(8*9)+(7*1)+(6*6)+(5*3)+(4*4)+(3*3)+(2*0)+(1*7)=162
162 % 10 = 2
So 916343-07-2 is a valid CAS Registry Number.

916343-07-2Upstream product

916343-07-2Downstream Products

916343-07-2Relevant academic research and scientific papers

Amide derivatives as somatostatin receptor 5 antagonists

-

Page/Page column 33, (2008/06/13)

This invention is concerned with compounds of the formula wherein R1 to R5, R5′ and A are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 916343-07-2